2694.0000 12.40 (0.46%)
NSE Dec 29, 2025 15:29 PM
Volume: 59,260
High vol. this week

2694.00
0.46%
ICICI Direct
Q2FY26- Momentum driven by US and India Business - Revenues grew ~14% YoY to 1354 crore driven by US and India branded business which grew ~48% / ~12% to 344 crore and 432 crore, respectively. Other branded businesses such as Asia and Africa witnessed the growth of 5% / 4% (on higher base) to 310 crore and 221 crore, respectively. On the operational front, EBITDA grew 5.4% YoY to ~328 crore (excluding forex losses of 41 crore, 9 % growth to ~369 crore) with margins at 24.2%...
Ajanta Pharma Ltd. has an average target of 2939.17 from 6 brokers.
More from Ajanta Pharma Ltd.
Recommended